Pfizer-Wyeth merger obtains clearance in U.S., Canada

10/15/2009 | Google

Pfizer is set to close its $68 billion takeover of Wyeth today after receiving approval from U.S. and Canadian regulators. The Federal Trade Commission, which required Pfizer to divest certain assets to "preserve competition," concluded that the deal "does not raise anti-competitive concerns in any human health-product markets."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID